A RETROSPECTIVE ANALYSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS TREATED WITH BEVACIZUMAB WITH OR WITHOUT IRINOTECAN: THE MOFFITT CANCER CENTER EXPERIENCE

被引:0
|
作者
Potthast, Lisa [1 ]
Chowdhary, Sajeel [1 ]
Pan, Edward [1 ]
Yu, Daohai [1 ]
Brem, Steven [1 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:831 / 831
页数:1
相关论文
共 50 条
  • [21] STEREOTACTIC RADIOTHERAPY FOR RECURRENT HIGH-GRADE GLIOMAS: A RETROSPECTIVE ANALYSIS
    Pinzi, V.
    Milanesi, I. M.
    Marchetti, M.
    Dimeco, F.
    Franzini, A.
    Ferroli, P.
    Silvani, A.
    Finocchiaro, G.
    Orsi, C.
    Fariselli, L.
    NEURO-ONCOLOGY, 2014, 16
  • [22] FDG-PET PREDICTS SURVIVAL IN RECURRENT HIGH GRADE GLIOMAS TREATED WITH BEVACIZUMAB AND IRINOTECAN
    Colavolpe, C.
    Chinot, O.
    Metellus, P.
    Mancini, J.
    Barrie, M.
    Bequet-Boucard, C.
    Tabouret, E.
    Mundler, O.
    Figarella-Branger, D.
    Guedj, E.
    NEURO-ONCOLOGY, 2012, 14 : 10 - 10
  • [23] A phase 1 study of mebendazole with bevacizumab and irinotecan in high-grade gliomas
    Krystal, Julie
    Hanson, Derek
    Donnelly, Danielle
    Atlas, Mark
    PEDIATRIC BLOOD & CANCER, 2024, 71 (04)
  • [24] Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab
    Brett J. Theeler
    Benjamin Ellezam
    Shlomit Yust-Katz
    John M. Slopis
    Monica E. Loghin
    John F. de Groot
    Journal of Neurology, 2014, 261 : 1559 - 1564
  • [25] Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab
    Theeler, Brett J.
    Ellezam, Benjamin
    Yust-Katz, Shlomit
    Slopis, John M.
    Loghin, Monica E.
    de Groot, John F.
    JOURNAL OF NEUROLOGY, 2014, 261 (08) : 1559 - 1564
  • [26] Treatment with bevacizumab and irinotecan for recurrent high-grade glial tumors
    Bokstein, Felix
    Shpigel, Shulim
    Blumenthal, Deborah T.
    CANCER, 2008, 112 (10) : 2267 - 2273
  • [27] Bevacizumab for patients with recurrent high grade gliomas
    Gilbert, Mark R.
    CANCER INVESTIGATION, 2007, 25 : 1 - 1
  • [28] A pilot study of forbretabulin with bevacizumab in recurrent high-grade gliomas
    Altaha, R.
    Almubarak, M.
    Newton, M. D.
    Torres-Trejo, A.
    Marano, G.
    Hobbs, G.
    Gibson, L.
    Petros, W. P.
    Remick, S. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
    Detti, Beatrice
    Scoccianti, Silvia
    Teriaca, Maria Ausilia
    Maragna, Virginia
    Lorenzetti, Victoria
    Lucidi, Sara
    Bellini, Chiara
    Greto, Daniela
    Desideri, Isacco
    Livi, Lorenzo
    RADIOLOGIA MEDICA, 2021, 126 (09): : 1249 - 1254
  • [30] Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
    Beatrice Detti
    Silvia Scoccianti
    Maria Ausilia Teriaca
    Virginia Maragna
    Victoria Lorenzetti
    Sara Lucidi
    Chiara Bellini
    Daniela Greto
    Isacco Desideri
    Lorenzo Livi
    La radiologia medica, 2021, 126 : 1249 - 1254